Pendulum To Swing To More Congressional Oversight Of FDA Device Regs, Hill Experts Say

In the context of a global investigation of the device industry and a change in power in the US House, health-policy experts say oversight by Congress of FDA's regulation of devices in 2019 is likely to swing incrementally away from ensuring innovation of products and easy market access, toward greater assurance of product safety before devices reach the market.

Magnifying glass-FDA_418713547_1200.jpg

Growing public scrutiny of the medical device industry and changes in political leadership in the US House suggest FDA oversight of devices could be elevated as a target for congressional oversight hearings in 2019, health-policy experts said Nov. 27.

“We have this pendulum of oversight of FDA regulation. It goes back and forth between more regulations and safety, and...

More from Legislation

More from Policy & Regulation